Palo Alto Investors’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-666,127
Closed -$1.3M 30
2023
Q2
$1.3M Hold
666,127
0.1% 28
2023
Q1
$1.85M Hold
666,127
0.15% 24
2022
Q4
$2.3M Sell
666,127
-1,664,377
-71% -$4.75M 0.2% 22
2022
Q3
$5.99M Hold
2,330,504
0.47% 20
2022
Q2
$5.64M Hold
2,330,504
0.49% 22
2022
Q1
$9.6M Sell
2,330,504
-25,778
-1% -$137K 0.74% 21
2021
Q4
$30.3M Hold
2,356,282
1.94% 16
2021
Q3
$25.4M Hold
2,356,282
1.54% 17
2021
Q2
$21.5M Buy
2,356,282
+57,900
+3% +$535K 1.19% 18
2021
Q1
$21.7M Buy
+2,298,382
New +$31.7M 1.23% 19

Other funds holding GRTS

Palo Alto Investors's GRTS Position: Q3 2023 in Review

Palo Alto Investors sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2023, closing a stake of 666,127 shares — an estimated $1.3M sold.

Palo Alto Investors first reported a position in GRTS in Q1 2021 and held it in 10 quarters. The position peaked at $30.3M in Q4 2021. 89 funds tracked by Wall St. Rank hold GRTS as of Q3 2023.

  • Palo Alto Investors reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Palo Alto Investors sold 666,127 Gritstone bio, Inc. Common Stock shares in Q3 2023, an estimated $1.3M.
  • Palo Alto Investors first reported a position in Gritstone bio, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
  • Palo Alto Investors's Gritstone bio, Inc. Common Stock position peaked at $30.3M in Q4 2021.
  • 89 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2023.

Based on Palo Alto Investors's 13F filing for Q3 2023, filed 14 Nov 2023.